11-124249784-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001002905.2(OR8G1):c.109G>A(p.Val37Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000211 in 1,613,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001002905.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR8G1 | NM_001002905.2 | c.109G>A | p.Val37Ile | missense_variant | 3/3 | ENST00000641972.1 | NP_001002905.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR8G1 | ENST00000641972.1 | c.109G>A | p.Val37Ile | missense_variant | 3/3 | NM_001002905.2 | ENSP00000493289.1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152044Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000599 AC: 15AN: 250250Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135670
GnomAD4 exome AF: 0.000217 AC: 317AN: 1461730Hom.: 0 Cov.: 32 AF XY: 0.000199 AC XY: 145AN XY: 727152
GnomAD4 genome AF: 0.000158 AC: 24AN: 152044Hom.: 0 Cov.: 31 AF XY: 0.0000943 AC XY: 7AN XY: 74254
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 02, 2024 | The c.109G>A (p.V37I) alteration is located in exon 1 (coding exon 1) of the OR8G1 gene. This alteration results from a G to A substitution at nucleotide position 109, causing the valine (V) at amino acid position 37 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at